Medios AG (ILM1.DE) Stock

Healthcare · Medical Distribution · Member of SDAX

Medios AG (ILM1.DE) closed at EUR 10.26 on 2026-10-14, a change of -17.7 % over the past year, with a market capitalization of EUR 259.65M.

Medios AG recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Medios AG key figures

Previous close

EUR 10.26 (2026-10-14)

1-year change

-17.7 %

Market cap

EUR 259.65M

Enterprise value

EUR 365.05M

P/E ratio (trailing)

22.62

P/E ratio (forward)

6.71

EPS (trailing)

0.45

EPS (forward)

1.52

PEG ratio

n/a

Price to book

0.48

Revenue growth

8 %

Earnings growth

-41.5 %

Dividend per share (trailing)

0.00

Short ratio

n/a

Employees

989

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Medios AG and compare it with other stocks.